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article under the CC BY-NC-ND licenseAbstract Objective: Despite a multitude of minimally invasive surgical options available for
benign prostatic enlargement, open simple prostatectomy (OSP) remains the standard for large
prostates (typically greater than 100 g). OSP, however, is associated with significant morbidity.
Recently, a few reports touting robotic application to simple prostatectomy have been pub-
lished. Herein, we reviewed our series of robotic assisted laparoscopic simple suprapubic pros-
tatectomy (RALSSP) and detailed modifications in our technique as our experience increased.
Methods: All RALSSP cases performed between January 2013 and January 2014 were reviewed
for demographics, pre-operative features, and perioperative outcomes. All parameters were
tabulated and mean values were calculated. Student’s t-test was utilized with p < 0.05
deemed significant. Details regarding surgical technique were reviewed and highlighted.
Results: Fifteen patients underwent RALSSP during this period. Mean age of these men was
68.7 years. Mean body mass index (BMI) was 28.5 kg/m2. American Society of Anesthesiologists
(ASA) score was on average 2.6. Average International Prostate Symptom Score (IPSS) was 16.2
with the majority of men experiencing some adverse clinical sequela of such benign prostatic
hyperplasia (BPH). For those patients not in retention, preoperative post-void residual (PVR)
was 428 mL. All patients underwent successful RALSSP without need for conversion or need
for blood transfusion. Mean estimated blood loss (EBL) was 290 mL. Five patients underwent
other concurrent procedures (e.g., cystolithotomy). Mean length of hospital stay (LOS) was
2.4 days and only five patients required continuous bladder irrigation (CBI) postoperatively.
Postoperative PVR improved to a mean of 33 mL and IPSS improved to 4.5 (p < 0.001). No major
complications were identified. Adaptation of low transverse cystotomy, utilization of a robotic
tenaculum in the #3 arm with its control by a surgeon on a second console, and the utilization(L. Richstone).
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56 S.E. Elsamra et al.of mucosal advancement have all subjectively aided in performance of RALSSP and perioper-
ative outcomes.
Conclusion: RALSSP allows for feasible performance of prostate adenoma enucleation with low
risk of blood transfusion, short LOS, and significant improvement in IPSS and PVR; all while
maintaining a minimally invasive approach. The use of a robotic tenaculum controlled by
the secondary console and the mucosal advancement facilitate excellent outcomes and may
play a role in minimizing hematuria and need for CBI.
ª 2014 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A large variety of options to treat obstructive voiding
symptoms and hematuria due to benign prostatic hyper-
plasia (BPH) has developed over the last decade. Given the
patient population requiring such therapy, elderly men
often with severe cardiovascular conditions and other co-
morbidities, each new medication or procedure has had the
goal of reducing the invasiveness and morbidity of treat-
ment while maintaining effective outcomes [1]. As a result,
the use of various techniques such as laser vaporization and
enucleation, plasma vaporization, bipolar resection [2],
and prostate embolization [3] have proliferated. Despite
these advancements, the standard treatment for obstruc-
tive urinary symptoms due to large-gland (greater than
100 g) BPH remains open simple prostatectomy (OSP) [4].
Minimally invasive techniques emulating OSP have
recently been developed and may improve perioperative
morbidity with equivalent treatment outcomes. Robotic
assisted laparoscopic simple suprapubic prostatectomy
(RALSSP) has previously been described as a novel alter-
native to OSP [5]. We describe our initial experience with
RALSSP and modifications we have adapted our technique
to improve efficiency.
2. Patients and methods
2.1. Patient demographics and outcomes
A retrospective chart review was conducted on all patients
who underwent RALSSP between January 2013 and January
2014. Outpatient records were reviewed for age, body mass
index (BMI), prostate specific antigen (PSA) value, Inter-
national Prostate Symptom Score (IPSS), prostate volume
(cm3), post-void residual (PVR), and BPH related compli-
cations (urinary retention, need for indwelling foley cath-
eter, urinary tract infection, gross hematuria, bladder
outlet obstruction with evidence of bilateral hydro-
nephrosis). The formula for volume of an ellipsoid
(length  width  height  p/6) was utilized to approxi-
mate the preoperative prostate volume with such mea-
surements obtained from transrectal ultrasound, MRI, or CT
[6]. Inpatient charts were reviewed for perioperative pa-
rameters including: operative details for procedure, oper-
ative time, estimated blood loss (EBL), American Society of
Anesthesiologists (ASA) score, and intraoperative compli-
cations. Pathology was reviewed for histology, concomitantpathology, and size of adenoma enucleated. Patient out-
comes were reviewed.
2.2. Procedure details
Patients with a large prostatic gland precluding transure-
thral approach, or those with other pathology necessitating
a transperitoneal approach (e.g., large bladder stones or
large bladder diverticula), were educated regarding the
risks and benefits and consented for RALSSP. All patients
were cleared for surgery by their primary care physicians
and/or cardiologists and the pre-surgical testing clinic. No
bowel prep was required.
After induction of general anesthesia and administration
of an intravenous first generation cephalosporin (or other
culture directed antibiotic) the patient was secured the
operating table with all pressure-points well padded. All
patients tolerated the dorsal lithotomy position in steep
Trendelenberg. Based on surgeon preference, a cystoscopy
and bilateral ureteral stent placement is performed to
better identify the ureteral orfices ahead of the RALSSP.
Pneumoperitoneum was established utilizing Veress needle
technique and set to 15 mmHg. A 12-mm port (for the
laparoscope) is placed peri-umbilically and two 8-mm ro-
botic trocar ports are placed 10 cm lateral, on either side,
to the camera port. Two assistant ports are positioned on
the patient’s left side; a 12-mm airseal trocar, 10 cm lateral
to the left sided robotic port, and a 5-mm port 8 cm su-
perior and 4 cm lateral to the camera port.
After the robot is docked, the anterior peritoneum is
incised on the lateral aspect of both medial umbilical lig-
aments in order to create the space of Retzius. Both medial
umbilical ligaments and the urachus are transected supe-
rior to the dome of the bladder and the bladder is effec-
tively dropped posteriorly. The prostate is cleared of fat
anteriorly in order to facilitate identification of its anat-
omy. The Foley catheter is also advanced and retracted in
order to delineate the bladder neck. A transverse cys-
totomy 2 cm cephalad to the bladder neck allows for
adequate exposure of the prostate gland within the
bladder. Both ureteral orfices are identified. If bladder
stones are present, they are grasped and placed into an
endocatch bag for subsequent extraction at this point. The
mucosa overlying the prostate is scored, roughly 1e2 cm
caudal to the trigone and this incision is continued cir-
cumferentially towards the anterior aspect of the prostate.
Early in our series we utilized a 2-0 vicryl stay suture placed
into the adenoma in order to aid in retraction, but we have
Figure 3 Obliterated fossa.
Figure 1 Tenaculum retracting adenoma.
Table 1 Perioperative outcomes (n Z 15).
Variable Value
Operative time (min)a 189 (127e289)
EBL (mL)a 290 (100e500)
Concurrent proceduresb 5 (33.3)
Blood transfusionsb 0 (0)
Conversionsb 0 (0)
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robotic tenaculum for such retraction (Fig. 1). The assistant
aids in suctioning of any blood and urine and with retraction
of the prostatic capsule to allow for optimal visualization of
the proper plane between the prostatic adenoma and the
prostatic capsule. Diathermy is utilized to dissect along the
contour of the prostate in this fashion, with advancement
made incrementally around the periphery of the gland until
the apex is transected from the urethra and the prostatic
adenoma is completely freed. The adenoma is then placed
into the endo-catch bag and placed aside for subsequent
extraction. Remaining is the prostatic fossa (Fig. 2). 2-0 V-
loc suture is then utilized to obtain hemostasis with a
running whip stitch that incorporates the bladder neck
vessels, classically located at the 7 O-clock and 5 O-clock
position at the level of the bladder neck. A subsequent
vesico-urethral advancement is performed utilizing a 3-0 V-
loc suture to obliterate the space in the posterior prostatic
fossa and facilitate subsequent foley catheter insertion or
exchange (Fig. 3). A 24-Fr 3-way Foley catheter is then
inserted and the cystotomy is repaired in two layers
(running 3-0 V-loc for the mucosa/muscularis and an
imbricating 2-0 V-loc for the serosa/muscularis). Irrigation
of the foley catheter confirms a water-tight closure, the
absence of any other capsular perforations, and ensures
patency of the catheter.Figure 2 Open prostatic fossa.3. Results
Fifteen patients underwent RALSSP during the study dura-
tion. Patients were of a mean age of 68.7 years (range:
58e78 years),meanBMI of 28.5 kg/m2 (range: 23e39 kg/m2),
and a mean ASA score of 2.6 (range 2e4). Average prostate
volume was 156 cm3 (range: 61e255 cm3) and average PSA
was 10.81 mg/dL (range:4.17e17.50 mg/dL). Mean preop-
erative PVR was 428 mL (range: 35e1054 mL). Many patients
suffered from untoward sequela of BPH prior to treatment:
six (40%) had a history of urinary retention, four (27%) were
catheter dependent, seven (47%) had a history of urinary
tract infections, four (27%) had gross hematuria, three (20%)Length of hospital stay (d)c 2.4 (1e6), 2
No. patients requiring CBIb 5 (33.3)
Length of catheter duration (d)a 8.67 (6e20)
Preoperative HGB (g/dL)a 12.6 (8.6e16.2)
Postoperative day#1 HGB (g/dL)a 11.5 (8.3e14.5)
Postoperative PVR (mL)c 33 (0e100), 25
IPSS score postoperativelyc 4.5 (0e8), 5




EBL, estimated blood loss; CBI, continuous bladder irrigation;
HGB, hemoglobin; PVR, post-void residual.
a Data presented as mean (range).
b Data presented as No. (%).
c Data presented as mean (range), median.
d Large prostatic capsular perforation.
e Superficial wound infection-Rx w abx.
f Urosepsis and Clostridium difficile infection requiring
hospitalization.
58 S.E. Elsamra et al.had bladder stones, and one (7%) had a large bladder
diverticulum. Four (27%) patients in our cohort underwent,
unsuccessfully, prior surgical treatments of their BPH.
Perioperative data are highlighted in Table 1. Mean
operative time was 189 min (range: 127e289 min). Mean
estimated blood loss (EBL) was 290 mL (range: 100e500 mL).
Mean length of hospital stay (LOS) was 2.4 days (range: 1e6
days, median 2 days). Change in hemoglobin was noted to be
1.1 ng/dL (range: 2.4 to 0.3 ng/dL). No patients in our
series required a blood transfusion or conversion to open
surgery. Only five (33%) patients of the 15 required contin-
uous bladder irrigation (CBI) postoperatively. Mean Foley
catheter duration was 8.67 days (range: 6e20 days). One
intraoperative complication was identified. A significant
capsular perforation, which was not repairable due to the
friability of the prostatic capsule necessitated a formal
vesico-urethral anastamosis be performed (similar to the
von-Velthoven technique utilized for radical prostatec-
tomy). Only two postoperative complications were identi-
fied (one Clavien grade 1 and one Clavien grade 2). One
patient demonstrated erythema at the extraction port site
and was treated with antibiotics for 2 weeks. Another pa-
tient (ASA 4) developed urosepsis postoperatively and
required readmission and hospitalization. He also developed
Clostridium difficile colitis but ultimately made a full re-
covery. No patients developed gross hematuria after
discharge requiring catheterization or treatment.
3.1. Specimens and pathology
Mean weight of prostate adenoma excised is 110 g. All
specimens were consistent with BPH with only one spec-
imen containing Gleason 3 þ 3 prostate cancer in less than
5% of the enucleated specimen.
3.2. Functional outcomes
All patients reported significant improvement in lower uri-
nary tract symptoms. PVR significantly improved to a mean
of 33 mL (range 0e100 mL, paired t-test, p < 0.001). IPSS
scores improved from mean of 16.2 to 4.5 (paired t-test,
p < 0.001). Three patients developed stress urinary incon-
tinence beyond 3 months, all of whom reported it to be
“mild” with pad use ranging from one to three pads per day.
Two patients complained of decrease in erectile functionTable 2 Summary of prior studies.




Vora et al. [5] 13 163 127
Sotelo et al. [9] 7 78 51
John et al. [10] 13 100 82
Uffort and Jensen [11] 15 71 46
Sutherland et al. [12] 9 137 112
Coelho et al. [13] 6 157 145
Matei et al. [14] 35 107 87
Leslie et al. [15] 25 150 88
Current study 15 157 110
a Data presented as mean values. EBL, estimated blood loss; LOS, land were improved with the use of oral phosphodiesterase-5
inhibitors.
4. Discussion
Despite the myriad of surgical procedures available for the
treatment of BPH, few options remain available for large
glands (>100 g). OSP, either suprapubic or retropubic, were
long unchallenged as the sole treatment options for the
surgical extirpation of such large prostate glands. In addi-
tion, such approaches have allowed for the treatment of
associated sequela of such BPH, such as bladder stones or
diverticula. Unfortunately, the surgical incision necessary
for the OSP and the associated bleeding from within the
prostatic fossa are often associated with significant
morbidity, need for blood transfusion, and convalescence.
Several centers have attempted to adopt a minimally
invasive approach to simple prostatectomy with the promise
of decreasing morbidity. Laparoscopic simple prostatectomy
was first described by Mariano et al. [7] in 2002 with much
enthusiasm. A subsequent cohort comparison however
demonstrated that laparoscopic simple prostatectomy was
associatedwithahigher transfusion ratecomparedwithopen
[8]. The technical demands of laparoscopic suturing for he-
mostasis were certainly felt to be a factor for this outcome.
Numerous groups have since utilized the da Vinci robotic
surgical platform to overcome such difficulties. With its
associated magnified vision and articulating instruments,
the da Vinci robot has been touted as the modality par
excellence for minimally invasive surgery that requires
complex intracorporeal reconstruction/suturing.
Several groups have recently published their experience
with robotic simple prostatectomy [5,9e15]. Table 2 sum-
marizes their associated findings. Interestingly, there are
many variations to the technique that can be elucidated
from the literature. First, for simple suprapubic prostatec-
tomies, access to the bladder is typically performed in a
longitudinal fashion when performed opendwith stay su-
tures placed for retraction of the bladder wall on either
side. While this has persisted in some of the reports, many
have favored a transverse incision just proximal to the
bladder neck. We have found that this negates the need for
stay suture retraction and allows excellent exposure of the
adenoma. Secondly, some reports suggest the need to su-






219 0 2.7 8.8
298 14 1.4 7
500 0 6 6
139 0 2.5 4.6
206 0 1.3 13
208 0 1 4.8
121 0 3.2 7.4
143 4 4 9
290 0 2.4 8.67
ength of hospital stay.
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series. Thirdly, we have previously utilized a 2-0 vicryl su-
ture placed into the adenoma for retraction, as described in
earlier series. We have found that this suture often rips
through the adenoma and may require multiple re-
placements. Recently we adapted the use of a robotic te-
naculum which allows for firm retraction of the adenoma
that can be easily repositioned. After the adenoma is
removed, a 2-0 V-loc suture is utilized to obliterate the
space within the prostatic fossa and attain hemostasis in a
running fashion. A 3-0 V-loc suture is then utilized to anas-
tomose the posterior bladder neck to the posterior mem-
branous urethra. We presume that this aids in hemostasis
and allows for more facile placement of Foley catheter.
As described above our technique has undergone many
adjustments which, we find facilitate the surgery. First we
abandoned the utilization of a longitudinal cystotomy for
the caudal transverse cystotomy. The low-transverse cys-
totomy allows for a smaller incision in the bladder while the
Trendelenberg position allows the superior bladder to drop
out of the way obviating the need for stay sutures. Based on
such excellent exposure afforded by the low transverse
cystotomy, the facile visualization of the trigonal ridge and
the ureteral orfices has negated our need to perform intra-
operative cystoscopy and ureteral stent insertion, as was
commonly performed early in our experience. Secondly we
have abandoned the use of stay sutures placed into the
prostate adenoma for the robotic tenaculum. The robotic
tenaculum in the #3 arm (can be exchanged for the #1 arm if
access to the right dissection plane is difficult) allows for
excellent traction of the gland with, in our opinion, less risk
of tearing through the adenoma or the need for adjustment
of the stay suture as more adenoma is delivered. The third
technical implementation, is allowing for an assistant sur-
geon on the second robotic console to control the robotic
tenaculum. This facilitates what we call “dynamic traction”
and decreases the need for repetitive clutching by the sur-
geon to adjust the traction as progress is being made. While,
we do not advocate for this when an available assistant is not
available, we are convinced that second robotic console
control of the robotic tenaculum decreases time necessary
to repetitively toggle control to the fourth arm to provide
appropriate traction. We believe that these techniques have
resulted in the improvement of several operative parame-
ters (EBL and OR time) as our experience has increased.
Our report reveals outcomes similar to previous reports
on RALSSP. Though our report is limited by small cohort,
this article highlights unique attributes of our technique
and its rapid evolution over our initial experience. Ideally,
such outcomes should be compared to open suprapubic
prostatectomy, though the paucity of such cases precludes
fruitful comparison at our institution. Further, Holmium
Laser Enucleation of the Prostate (HoLEP) has enjoyed
significant attention recently as a minimally invasive
alternative to open surprapubic prostatectomy, and ideally
comparision of RALSSP to HoLEP should be included. How-
ever, HoLEP is technically difficult and not offered in many
centers, whereas the da Vinci robotic platform has become
widespread. Nonetheless, this report represents one of the
larger series on RALSSP demonstrating feasibility and su-
periority compared to historical open simple prostatectomy
series outcomes.5. Conclusion
RALSSP mimics open simple prostatectomy with improve-
ments in morbidity, blood loss, and convalescence, though
our study does not provide a direct comparison. The use of
a low transverse cystotomy and the robotic tenaculum (if
possible controlled by the surgeon at the second console
allowing for dynamic retraction) facilitates the procedure.
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